Niemann Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Niemann Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,745	Closed	-$239K	–	16
2020 Q2	$239K	Buy	+1,745	New	+$222K	0.31%	47
2015 Q4	–	Sell	-25,632	Closed	-$2.59M	–	14
2015 Q3	$2.59M	Sell	25,632 -81,282	-76%	-$9.75M	3.93%	10
2015 Q2	$13.1M	Sell	106,914 -5,622	-5%	-$673K	9.38%	3
2015 Q1	$12.9M	Sell	112,536 -5,064	-4%	-$559K	8.7%	4
2014 Q4	$11.9M	Sell	117,600 -6,387	-5%	-$621K	8.46%	5
2014 Q3	$11.3M	Sell	123,987 -5,478	-4%	-$481K	8.11%	5
2014 Q2	$11.1M	Sell	129,465 -75,864	-37%	-$5.98M	7.58%	6
2014 Q1	$16.2M	Sell	205,329 -558	-0.3%	-$46.5K	11.01%	2
2013 Q4	$15.6M	Sell	205,887 -11,301	-5%	-$802K	10.74%	2
2013 Q3	$15.2M	Sell	217,188 -21,360	-9%	-$1.4M	10.92%	1
2013 Q2	$13.8M	Buy	+238,548	New	+$13.8M	11.39%	2

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Niemann Capital Management's IBB Position: Q3 2020 in Review

Niemann Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 1,745 shares — an estimated $239K sold.

Niemann Capital Management first reported a position in IBB in Q2 2013 and held it in 11 quarters. The position peaked at $16.2M in Q1 2014. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

Niemann Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
Niemann Capital Management sold 1,745 iShares Biotechnology ETF shares in Q3 2020, an estimated $239K.
Niemann Capital Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 11 quarters.
Niemann Capital Management's iShares Biotechnology ETF position peaked at $16.2M in Q1 2014.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on Niemann Capital Management's 13F filing for Q3 2020, filed 10 Nov 2020.